Implementation of a Market Entry Reward within the United States.
Identifieur interne : 000944 ( Main/Exploration ); précédent : 000943; suivant : 000945Implementation of a Market Entry Reward within the United States.
Auteurs : Gregory W. Daniel ; Monika Schneider ; Marianne Hamilton Lopez ; Mark B. McclellanSource :
- The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [ 1748-720X ] ; 2018.
Descripteurs français
- KwdFr :
- MESH :
- Wicri :
- geographic : États-Unis.
English descriptors
- KwdEn :
- MESH :
- chemical , economics : Anti-Bacterial Agents.
- geographic : United States.
- economics : Drug Discovery.
- Drug Resistance, Microbial, Health Policy, Humans, Reward, Risk Sharing, Financial.
Abstract
As part of a multifactorial approach to address weak incentives for innovative antimicrobial drug development, market entry rewards (MERs) are an emerging solution. Recently, the Duke-Margolis Center for Health Policy released the Priority Antimicrobial Value and Entry (PAVE) Award proposal, which combines a MER with payment reforms, transitioning from volume-based to "value-based" payments for antimicrobials. Here, the PAVE Award and similar MERs are reviewed, focusing on further refinement and avenues for implementation.
DOI: 10.1177/1073110518782915
PubMed: 30146957
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000798
- to stream PubMed, to step Curation: 000798
- to stream PubMed, to step Checkpoint: 000888
- to stream Ncbi, to step Merge: 001F44
- to stream Ncbi, to step Curation: 001F44
- to stream Ncbi, to step Checkpoint: 001F44
- to stream Main, to step Merge: 000947
- to stream Main, to step Curation: 000944
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Implementation of a Market Entry Reward within the United States.</title><author><name sortKey="Daniel, Gregory W" sort="Daniel, Gregory W" uniqKey="Daniel G" first="Gregory W" last="Daniel">Gregory W. Daniel</name><affiliation><nlm:affiliation>Gregory W. Daniel, Ph.D., M.P.H., R.Ph., is the Deputy Director of the Robert J. Margolis, MD, Center for Health Policy and a Clinical Professor in the Fuqua School of Business at Duke University. He received his B.S. in Pharmacy, M.S. in Pharmaceutical Administration, and M.P.H. in Biostatistics from the Ohio State University and his Ph.D. in Pharmaceutical Economics, Policy, and Outcomes from the University of Arizona. Monika Schneider, Ph.D., is a Research Associate at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.S. in Biological Sciences from Butler University and her Ph.D. in Microbiology and Immunology at the University of North Carolina, Chapel Hill. Marianne Hamilton Lopez, Ph.D., is a Research Director at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.A. in Politics and Women's Studies from Earlham College, her M.P.A. from the George Washington University, and her Ph.D. in Public Policy from the University of Maryland, Baltimore County. Mark B. McClellan, M.D., Ph.D., is the Director of the Robert J. Margolis, MD, Center for Health Policy and the Robert J. Margolis, MD, Professor of Business, Medicine and Policy, with appointments as Professor of the Practice of Business Administration in the Fuqua School of Business and Professor of the Practice in the Sanford School of Public Policy at Duke University. He received his B.A. at the University of Texas, Austin, his M.P.A. from Harvard University, his M.D. from the Harvard-MIT Division of Health Sciences and Technology, and his Ph.D. from the Massachusetts Institute of Technology.</nlm:affiliation><wicri:noCountry code="subField">and his Ph.D.</wicri:noCountry></affiliation></author><author><name sortKey="Schneider, Monika" sort="Schneider, Monika" uniqKey="Schneider M" first="Monika" last="Schneider">Monika Schneider</name><affiliation><nlm:affiliation>Gregory W. Daniel, Ph.D., M.P.H., R.Ph., is the Deputy Director of the Robert J. Margolis, MD, Center for Health Policy and a Clinical Professor in the Fuqua School of Business at Duke University. He received his B.S. in Pharmacy, M.S. in Pharmaceutical Administration, and M.P.H. in Biostatistics from the Ohio State University and his Ph.D. in Pharmaceutical Economics, Policy, and Outcomes from the University of Arizona. Monika Schneider, Ph.D., is a Research Associate at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.S. in Biological Sciences from Butler University and her Ph.D. in Microbiology and Immunology at the University of North Carolina, Chapel Hill. Marianne Hamilton Lopez, Ph.D., is a Research Director at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.A. in Politics and Women's Studies from Earlham College, her M.P.A. from the George Washington University, and her Ph.D. in Public Policy from the University of Maryland, Baltimore County. Mark B. McClellan, M.D., Ph.D., is the Director of the Robert J. Margolis, MD, Center for Health Policy and the Robert J. Margolis, MD, Professor of Business, Medicine and Policy, with appointments as Professor of the Practice of Business Administration in the Fuqua School of Business and Professor of the Practice in the Sanford School of Public Policy at Duke University. He received his B.A. at the University of Texas, Austin, his M.P.A. from Harvard University, his M.D. from the Harvard-MIT Division of Health Sciences and Technology, and his Ph.D. from the Massachusetts Institute of Technology.</nlm:affiliation><wicri:noCountry code="subField">and his Ph.D.</wicri:noCountry></affiliation></author><author><name sortKey="Lopez, Marianne Hamilton" sort="Lopez, Marianne Hamilton" uniqKey="Lopez M" first="Marianne Hamilton" last="Lopez">Marianne Hamilton Lopez</name><affiliation><nlm:affiliation>Gregory W. Daniel, Ph.D., M.P.H., R.Ph., is the Deputy Director of the Robert J. Margolis, MD, Center for Health Policy and a Clinical Professor in the Fuqua School of Business at Duke University. He received his B.S. in Pharmacy, M.S. in Pharmaceutical Administration, and M.P.H. in Biostatistics from the Ohio State University and his Ph.D. in Pharmaceutical Economics, Policy, and Outcomes from the University of Arizona. Monika Schneider, Ph.D., is a Research Associate at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.S. in Biological Sciences from Butler University and her Ph.D. in Microbiology and Immunology at the University of North Carolina, Chapel Hill. Marianne Hamilton Lopez, Ph.D., is a Research Director at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.A. in Politics and Women's Studies from Earlham College, her M.P.A. from the George Washington University, and her Ph.D. in Public Policy from the University of Maryland, Baltimore County. Mark B. McClellan, M.D., Ph.D., is the Director of the Robert J. Margolis, MD, Center for Health Policy and the Robert J. Margolis, MD, Professor of Business, Medicine and Policy, with appointments as Professor of the Practice of Business Administration in the Fuqua School of Business and Professor of the Practice in the Sanford School of Public Policy at Duke University. He received his B.A. at the University of Texas, Austin, his M.P.A. from Harvard University, his M.D. from the Harvard-MIT Division of Health Sciences and Technology, and his Ph.D. from the Massachusetts Institute of Technology.</nlm:affiliation><wicri:noCountry code="subField">and his Ph.D.</wicri:noCountry></affiliation></author><author><name sortKey="Mcclellan, Mark B" sort="Mcclellan, Mark B" uniqKey="Mcclellan M" first="Mark B" last="Mcclellan">Mark B. Mcclellan</name><affiliation><nlm:affiliation>Gregory W. Daniel, Ph.D., M.P.H., R.Ph., is the Deputy Director of the Robert J. Margolis, MD, Center for Health Policy and a Clinical Professor in the Fuqua School of Business at Duke University. He received his B.S. in Pharmacy, M.S. in Pharmaceutical Administration, and M.P.H. in Biostatistics from the Ohio State University and his Ph.D. in Pharmaceutical Economics, Policy, and Outcomes from the University of Arizona. Monika Schneider, Ph.D., is a Research Associate at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.S. in Biological Sciences from Butler University and her Ph.D. in Microbiology and Immunology at the University of North Carolina, Chapel Hill. Marianne Hamilton Lopez, Ph.D., is a Research Director at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.A. in Politics and Women's Studies from Earlham College, her M.P.A. from the George Washington University, and her Ph.D. in Public Policy from the University of Maryland, Baltimore County. Mark B. McClellan, M.D., Ph.D., is the Director of the Robert J. Margolis, MD, Center for Health Policy and the Robert J. Margolis, MD, Professor of Business, Medicine and Policy, with appointments as Professor of the Practice of Business Administration in the Fuqua School of Business and Professor of the Practice in the Sanford School of Public Policy at Duke University. He received his B.A. at the University of Texas, Austin, his M.P.A. from Harvard University, his M.D. from the Harvard-MIT Division of Health Sciences and Technology, and his Ph.D. from the Massachusetts Institute of Technology.</nlm:affiliation><wicri:noCountry code="subField">and his Ph.D.</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:30146957</idno><idno type="pmid">30146957</idno><idno type="doi">10.1177/1073110518782915</idno><idno type="wicri:Area/PubMed/Corpus">000798</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000798</idno><idno type="wicri:Area/PubMed/Curation">000798</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000798</idno><idno type="wicri:Area/PubMed/Checkpoint">000888</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000888</idno><idno type="wicri:Area/Ncbi/Merge">001F44</idno><idno type="wicri:Area/Ncbi/Curation">001F44</idno><idno type="wicri:Area/Ncbi/Checkpoint">001F44</idno><idno type="wicri:Area/Main/Merge">000947</idno><idno type="wicri:Area/Main/Curation">000944</idno><idno type="wicri:Area/Main/Exploration">000944</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Implementation of a Market Entry Reward within the United States.</title><author><name sortKey="Daniel, Gregory W" sort="Daniel, Gregory W" uniqKey="Daniel G" first="Gregory W" last="Daniel">Gregory W. Daniel</name><affiliation><nlm:affiliation>Gregory W. Daniel, Ph.D., M.P.H., R.Ph., is the Deputy Director of the Robert J. Margolis, MD, Center for Health Policy and a Clinical Professor in the Fuqua School of Business at Duke University. He received his B.S. in Pharmacy, M.S. in Pharmaceutical Administration, and M.P.H. in Biostatistics from the Ohio State University and his Ph.D. in Pharmaceutical Economics, Policy, and Outcomes from the University of Arizona. Monika Schneider, Ph.D., is a Research Associate at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.S. in Biological Sciences from Butler University and her Ph.D. in Microbiology and Immunology at the University of North Carolina, Chapel Hill. Marianne Hamilton Lopez, Ph.D., is a Research Director at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.A. in Politics and Women's Studies from Earlham College, her M.P.A. from the George Washington University, and her Ph.D. in Public Policy from the University of Maryland, Baltimore County. Mark B. McClellan, M.D., Ph.D., is the Director of the Robert J. Margolis, MD, Center for Health Policy and the Robert J. Margolis, MD, Professor of Business, Medicine and Policy, with appointments as Professor of the Practice of Business Administration in the Fuqua School of Business and Professor of the Practice in the Sanford School of Public Policy at Duke University. He received his B.A. at the University of Texas, Austin, his M.P.A. from Harvard University, his M.D. from the Harvard-MIT Division of Health Sciences and Technology, and his Ph.D. from the Massachusetts Institute of Technology.</nlm:affiliation><wicri:noCountry code="subField">and his Ph.D.</wicri:noCountry></affiliation></author><author><name sortKey="Schneider, Monika" sort="Schneider, Monika" uniqKey="Schneider M" first="Monika" last="Schneider">Monika Schneider</name><affiliation><nlm:affiliation>Gregory W. Daniel, Ph.D., M.P.H., R.Ph., is the Deputy Director of the Robert J. Margolis, MD, Center for Health Policy and a Clinical Professor in the Fuqua School of Business at Duke University. He received his B.S. in Pharmacy, M.S. in Pharmaceutical Administration, and M.P.H. in Biostatistics from the Ohio State University and his Ph.D. in Pharmaceutical Economics, Policy, and Outcomes from the University of Arizona. Monika Schneider, Ph.D., is a Research Associate at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.S. in Biological Sciences from Butler University and her Ph.D. in Microbiology and Immunology at the University of North Carolina, Chapel Hill. Marianne Hamilton Lopez, Ph.D., is a Research Director at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.A. in Politics and Women's Studies from Earlham College, her M.P.A. from the George Washington University, and her Ph.D. in Public Policy from the University of Maryland, Baltimore County. Mark B. McClellan, M.D., Ph.D., is the Director of the Robert J. Margolis, MD, Center for Health Policy and the Robert J. Margolis, MD, Professor of Business, Medicine and Policy, with appointments as Professor of the Practice of Business Administration in the Fuqua School of Business and Professor of the Practice in the Sanford School of Public Policy at Duke University. He received his B.A. at the University of Texas, Austin, his M.P.A. from Harvard University, his M.D. from the Harvard-MIT Division of Health Sciences and Technology, and his Ph.D. from the Massachusetts Institute of Technology.</nlm:affiliation><wicri:noCountry code="subField">and his Ph.D.</wicri:noCountry></affiliation></author><author><name sortKey="Lopez, Marianne Hamilton" sort="Lopez, Marianne Hamilton" uniqKey="Lopez M" first="Marianne Hamilton" last="Lopez">Marianne Hamilton Lopez</name><affiliation><nlm:affiliation>Gregory W. Daniel, Ph.D., M.P.H., R.Ph., is the Deputy Director of the Robert J. Margolis, MD, Center for Health Policy and a Clinical Professor in the Fuqua School of Business at Duke University. He received his B.S. in Pharmacy, M.S. in Pharmaceutical Administration, and M.P.H. in Biostatistics from the Ohio State University and his Ph.D. in Pharmaceutical Economics, Policy, and Outcomes from the University of Arizona. Monika Schneider, Ph.D., is a Research Associate at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.S. in Biological Sciences from Butler University and her Ph.D. in Microbiology and Immunology at the University of North Carolina, Chapel Hill. Marianne Hamilton Lopez, Ph.D., is a Research Director at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.A. in Politics and Women's Studies from Earlham College, her M.P.A. from the George Washington University, and her Ph.D. in Public Policy from the University of Maryland, Baltimore County. Mark B. McClellan, M.D., Ph.D., is the Director of the Robert J. Margolis, MD, Center for Health Policy and the Robert J. Margolis, MD, Professor of Business, Medicine and Policy, with appointments as Professor of the Practice of Business Administration in the Fuqua School of Business and Professor of the Practice in the Sanford School of Public Policy at Duke University. He received his B.A. at the University of Texas, Austin, his M.P.A. from Harvard University, his M.D. from the Harvard-MIT Division of Health Sciences and Technology, and his Ph.D. from the Massachusetts Institute of Technology.</nlm:affiliation><wicri:noCountry code="subField">and his Ph.D.</wicri:noCountry></affiliation></author><author><name sortKey="Mcclellan, Mark B" sort="Mcclellan, Mark B" uniqKey="Mcclellan M" first="Mark B" last="Mcclellan">Mark B. Mcclellan</name><affiliation><nlm:affiliation>Gregory W. Daniel, Ph.D., M.P.H., R.Ph., is the Deputy Director of the Robert J. Margolis, MD, Center for Health Policy and a Clinical Professor in the Fuqua School of Business at Duke University. He received his B.S. in Pharmacy, M.S. in Pharmaceutical Administration, and M.P.H. in Biostatistics from the Ohio State University and his Ph.D. in Pharmaceutical Economics, Policy, and Outcomes from the University of Arizona. Monika Schneider, Ph.D., is a Research Associate at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.S. in Biological Sciences from Butler University and her Ph.D. in Microbiology and Immunology at the University of North Carolina, Chapel Hill. Marianne Hamilton Lopez, Ph.D., is a Research Director at the Robert J. Margolis, MD, Center for Health Policy at Duke University. She received her B.A. in Politics and Women's Studies from Earlham College, her M.P.A. from the George Washington University, and her Ph.D. in Public Policy from the University of Maryland, Baltimore County. Mark B. McClellan, M.D., Ph.D., is the Director of the Robert J. Margolis, MD, Center for Health Policy and the Robert J. Margolis, MD, Professor of Business, Medicine and Policy, with appointments as Professor of the Practice of Business Administration in the Fuqua School of Business and Professor of the Practice in the Sanford School of Public Policy at Duke University. He received his B.A. at the University of Texas, Austin, his M.P.A. from Harvard University, his M.D. from the Harvard-MIT Division of Health Sciences and Technology, and his Ph.D. from the Massachusetts Institute of Technology.</nlm:affiliation><wicri:noCountry code="subField">and his Ph.D.</wicri:noCountry></affiliation></author></analytic><series><title level="j">The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics</title><idno type="eISSN">1748-720X</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Bacterial Agents (economics)</term><term>Drug Discovery (economics)</term><term>Drug Resistance, Microbial</term><term>Health Policy</term><term>Humans</term><term>Reward</term><term>Risk Sharing, Financial</term><term>United States</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antibactériens (économie)</term><term>Découverte de médicament (économie)</term><term>Humains</term><term>Participation aux risques financiers</term><term>Politique de santé</term><term>Récompense</term><term>Résistance microbienne aux médicaments</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="MESH" type="chemical" qualifier="economics" xml:lang="en"><term>Anti-Bacterial Agents</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>United States</term></keywords><keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Drug Discovery</term></keywords><keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Antibactériens</term><term>Découverte de médicament</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Drug Resistance, Microbial</term><term>Health Policy</term><term>Humans</term><term>Reward</term><term>Risk Sharing, Financial</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Participation aux risques financiers</term><term>Politique de santé</term><term>Récompense</term><term>Résistance microbienne aux médicaments</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>États-Unis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">As part of a multifactorial approach to address weak incentives for innovative antimicrobial drug development, market entry rewards (MERs) are an emerging solution. Recently, the Duke-Margolis Center for Health Policy released the Priority Antimicrobial Value and Entry (PAVE) Award proposal, which combines a MER with payment reforms, transitioning from volume-based to "value-based" payments for antimicrobials. Here, the PAVE Award and similar MERs are reviewed, focusing on further refinement and avenues for implementation.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Daniel, Gregory W" sort="Daniel, Gregory W" uniqKey="Daniel G" first="Gregory W" last="Daniel">Gregory W. Daniel</name><name sortKey="Lopez, Marianne Hamilton" sort="Lopez, Marianne Hamilton" uniqKey="Lopez M" first="Marianne Hamilton" last="Lopez">Marianne Hamilton Lopez</name><name sortKey="Mcclellan, Mark B" sort="Mcclellan, Mark B" uniqKey="Mcclellan M" first="Mark B" last="Mcclellan">Mark B. Mcclellan</name><name sortKey="Schneider, Monika" sort="Schneider, Monika" uniqKey="Schneider M" first="Monika" last="Schneider">Monika Schneider</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000944 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000944 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:30146957
|texte= Implementation of a Market Entry Reward within the United States.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:30146957" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |